Annis Gardner Whiting Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83M Sell
19,005
-387
-2% -$90.2K 0.72% 18
2026
Q1
$4.74M Sell
19,392
-73
-0.4% -$17K 0.76% 18
2025
Q4
$4.03M Buy
19,465
+2,385
+14% +$472K 0.76% 16
2025
Q3
$3.17M Buy
17,080
+1,920
+13% +$329K 0.65% 21
2025
Q2
$2.32M Buy
15,160
+484
+3% +$74.4K 0.8% 19
2025
Q1
$2.43M Sell
14,676
-75
-0.5% -$11.7K 1.03% 12
2024
Q4
$2.13M Buy
14,751
+576
+4% +$89.3K 0.6% 25
2024
Q3
$2.3M Sell
14,175
-96
-0.7% -$15.3K 0.65% 18
2024
Q2
$2.09M Buy
14,271
+4,932
+53% +$734K 0.59% 21
2024
Q1
$1.48M Buy
9,339
+829
+10% +$132K 0.53% 26
2023
Q4
$1.33M Buy
8,510
+496
+6% +$76.1K 0.59% 26
2023
Q3
$1.25M Buy
+8,014
New +$1.32M 0.67% 22

Other funds holding JNJ

Annis Gardner Whiting Capital Advisors's JNJ Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, selling an estimated $90.2K and leaving 19,005 shares worth $4.83M. The position accounts for 0.72% of the portfolio, ranked #18.

Annis Gardner Whiting Capital Advisors first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 19,005 shares of Johnson & Johnson worth $4.83M as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 387 Johnson & Johnson shares in Q2 2026, an estimated $90.2K.
  • Johnson & Johnson made up 0.72% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #18 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.